SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000902219-15-000182
Filing Date
2015-02-12
Accepted
2015-02-12 10:44:09
Documents
1

Document Format Files

Seq Description Document Type Size
1 SEC SCHEDULE 13G SEC13G_Filing.htm SC 13G/A 18400
  Complete submission text file 0000902219-15-000182.txt   20151
Mailing Address 280 CONGRESS STREET BOSTON MA 02210
Business Address 280 CONGRESS STREET BOSTON MA 02210 6179515000
WELLINGTON MANAGEMENT GROUP LLP (Filed by) CIK: 0000902219 (see all company filings)

IRS No.: 042683227 | State of Incorp.: MA | Fiscal Year End: 1231
Type: SC 13G/A
SIC: 0000

Mailing Address 3535 GENERAL ATOMICS COURT SUITE 200 SAN DIEGO CA 92121
Business Address 3535 GENERAL ATOMICS COURT SUITE 200 SAN DIEGO CA 92121 858.875.1803
FATE THERAPEUTICS INC (Subject) CIK: 0001434316 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
Type: SC 13G/A | Act: 34 | File No.: 005-87649 | Film No.: 15603084
SIC: 2836 Biological Products, (No Diagnostic Substances)